Although there was no significant correlation between the expression of DBC1 and estrogen receptor in breast carcinoma [14], significant positive correlations between the expression of DBC1 and AR have been reported in clear cell renal cell carcinoma [12] and diffuse large B cell lymphoma [11]. This evidence concerns the gene CCAR2 and breast carcinoma.